Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | SLC22A12 | Q96S37 | 3/20 | 0.32 |
| ▸ | KIF11 | P52732 | 2/20 | 0.32 |
| ▸ | MAT2A | P31153 | 1/20 | 0.31 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23487720 | 0.96 | CSNK1D (0.31) | KDM4E | |
| SCHEMBL22563600 | 0.94 | SLC22A12 (0.32) | CYP1A2CYP2C9CYP2C19NPSR1SLC22A12 | |
| SCHEMBL19942754 | 0.92 | CYP1A2 (0.32) | CYP1A2CYP2C9CYP2C19NPSR1SLC22A12 | |
| SCHEMBL22563707 | 0.91 | KIF11 (0.43) | CYP1A2CYP2C9CYP2C19KIF11MAT2A | |
| SCHEMBL19909170 | 0.89 | NPSR1 (0.32) | CYP1A2CYP2C9CYP2C19NPSR1SLC22A12 | |
| SCHEMBL22563601 | 0.88 | CSNK1D (0.32) | CYP1A2CYP2C19NPSR1KDM4E | |
| SCHEMBL21108052 | 0.87 | ALDH1A1 (0.33) | — | |
| SCHEMBL23487338 | 0.87 | KDM4E (0.36) | CYP1A2CYP2C9CYP2C19NPSR1SLC22A12 | |
| SCHEMBL21279110 | 0.87 | SLC22A12 (0.31) | SLC22A12KIF11MAT2AKDM4E | |
| SCHEMBL22563711 | 0.86 | KIF11 (0.39) | CYP1A2CYP2C9CYP2C19KIF11MAT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210175434-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-06-10 | — | — | US | disclosed |
| EP-3580300-B1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2020-10-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210175434-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, OR51E2, OCIAD2 | CYP1A2 600/4885CYP2C9 336/4885CYP2C19 421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.